| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品收入(元) | 7,387,041.34 | - | 21,193,971.09 | - | 29,322,646.01 |
| 片剂药品收入(元) | - | 22,732,299.30 | - | 20,182,715.32 | - |
| 注射液药品收入(元) | - | 9,795,621.45 | - | 44,729,189.28 | - |
| 技术服务费(元) | - | - | 3,018,867.91 | - | - |
| 技术服务收入(元) | - | 3,018,867.91 | - | - | - |
| 营业成本(元) | |||||
| 药品收入(元) | 4,718,614.39 | - | 12,183,580.49 | - | 23,281,023.17 |
| 片剂药品收入(元) | - | 13,626,083.95 | - | 11,547,578.85 | - |
| 注射液药品收入(元) | - | 5,111,569.73 | - | 38,741,044.58 | - |
| 技术服务费(元) | - | - | - | - | - |
| 技术服务收入(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 药品收入(元) | 2,668,426.95 | - | 9,010,390.60 | - | 6,041,622.84 |
| 片剂药品收入(元) | - | 9,106,215.35 | - | 8,635,136.47 | - |
| 注射液药品收入(元) | - | 4,684,051.72 | - | 5,988,144.70 | - |
| 技术服务费(元) | - | - | 3,018,867.91 | - | - |
| 技术服务收入(元) | - | 3,018,867.91 | - | - | - |
| 毛利率(%) | |||||
| 药品收入(%) | 36.12 | - | 42.51 | - | 20.60 |
| 片剂药品收入(%) | - | 40.06 | - | 42.78 | - |
| 注射液药品收入(%) | - | 47.82 | - | 13.39 | - |
| 技术服务费(%) | - | - | - | - | - |
| 技术服务收入(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 药品收入(%) | 100.00 | - | 87.53 | - | 100.00 |
| 片剂药品收入(%) | - | 63.95 | - | 31.09 | - |
| 注射液药品收入(%) | - | 27.56 | - | 68.91 | - |
| 技术服务费(%) | - | - | 12.47 | - | - |
| 技术服务收入(%) | - | 8.49 | - | - | - |
| 毛利构成(%) | |||||
| 药品收入(%) | 100.00 | - | 74.90 | - | 100.00 |
| 片剂药品收入(%) | - | 54.17 | - | 59.05 | - |
| 注射液药品收入(%) | - | 27.87 | - | 40.95 | - |
| 技术服务费(%) | - | - | 25.10 | - | - |
| 技术服务收入(%) | - | 17.96 | - | - | - |